oral prodrug of serine _-lactamase inh.

in dev. for multidrug resistant bact. infection

from optimization of prior _-lactamase inh.

J. Med. Chem., Jul. 24, 2020

Entasis Therapeutics, Waltham, MA

Structure of orally available diazabicyclooctane inhibitor, ETX0282

ETX0282 is an oral prodrug of a class A, C, and D serine β-lactamase inhibitor in clinical development for drug-resistant enterobacterial infections in combination with the beta-lactam drug cefpodoxime proxetil.…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: